Foresight Autonomous Holdings Ltd. (TLV:FRSX)

Achilles Therapeutics Revenue

In the year 2024, Foresight Autonomous Holdings had annual revenue of $436.00K USD, down -12.27%. Foresight Autonomous Holdings had revenue of $101.00K in the quarter ending December 31, 2024, a decrease of -26.81%.

• Revenue: $436.00K
• Revenue Growth: -12.27%
• P/S Ratio: 22.45
• Revenue / Employee: $5.01K
• Employees: 87
• Market Cap: 35.65M

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	436.00K	-61.00K	-12.27%
Dec 31, 2023	497.00K	-53.00K	-9.64%
Dec 31, 2022	550.00K	430.00K	358.33%
Dec 31, 2021	120.00K	-	-
Dec 31, 2020	-	-	-